BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 208376)

  • 1. Distribution and regulation of the phosphodiesterases of muscle tissues.
    Gain KR; Appleman MM
    Adv Cyclic Nucleotide Res; 1978; 9():221-31. PubMed ID: 208376
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
    Strada SJ; Thompson WJ
    Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver.
    Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA
    Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of rat cerebral cortical 3',5'-cyclic nucleotide phosphodiesterase activity by gangliosides.
    Davis CW; Daly JW
    Mol Pharmacol; 1980 Mar; 17(2):206-11. PubMed ID: 6248757
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
    Manganiello VC; Yamamoto T; Elks M; Lin MC; Vaughan M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():291-301. PubMed ID: 6326529
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acupuncture on the activities of phosphodiesterases in rat brain.
    Zhang TJ; Ma CH; Sun SM; Dong XT; Lu ZS
    J Tradit Chin Med; 1985 Dec; 5(4):285-8. PubMed ID: 3010000
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase activities of the human liver: comparison between control and Reye's syndrome samples.
    Kang ES
    Pediatr Res; 1978 Jul; 12(7):761-6. PubMed ID: 211480
    [No Abstract]   [Full Text] [Related]  

  • 9. Age related changes in cardiac and aortic phosphodiesterase activities in normotensive and hypertensive rats.
    Lugnier C; Stoclet JC
    Biochem Pharmacol; 1979 Dec; 28(24):3581-7. PubMed ID: 231449
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiplicity within cyclic nucleotide phosphodiesterases.
    Rybalkin SD; Beavo JA
    Biochem Soc Trans; 1996 Nov; 24(4):1005-9. PubMed ID: 8968501
    [No Abstract]   [Full Text] [Related]  

  • 11. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
    Worby A; Mensah LM; Murray KJ
    Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

  • 13. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
    Perez de Gracia B; Rhoads AR; West WL
    Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
    Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
    Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterase activity in cardiac and vascular smooth muscle of the spontaneously hypertensive rat.
    Taylor JE; Shirachi DY
    Proc West Pharmacol Soc; 1977; 20():307-10. PubMed ID: 197543
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotide phosphodiesterase activity in the mussel Mytilus edulis L. [proceedings].
    Abreu-Grobois FA; Newton RP; Smith CJ
    Biochem Soc Trans; 1977; 5(5):1348-51. PubMed ID: 200501
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
    Donnelly TE
    Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM; Weiss B
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
    Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.